212 related articles for article (PubMed ID: 29462955)
41. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
[TBL] [Abstract][Full Text] [Related]
42. Cholesterol induces surface localization of polyphenols in model membranes thus enhancing vesicle stability against lysozyme, but reduces protection of distant double bonds from reactive-oxygen species.
de Athayde Moncorvo Collado A; Dupuy FG; Morero RD; Minahk C
Biochim Biophys Acta; 2016 Jul; 1858(7 Pt A):1479-87. PubMed ID: 27063609
[TBL] [Abstract][Full Text] [Related]
43. Remarkable Enhancement of Antioxidant Activity of the Ovalbumin-EGCG Conjugate through a Novel Preceding Selective Protection Grafting Strategy.
Wang Y; Liu S
J Agric Food Chem; 2024 Jun; 72(23):13320-13327. PubMed ID: 38819406
[TBL] [Abstract][Full Text] [Related]
44. (-)-Epigallocatechin gallate/gelatin layer-by-layer assembled films and microcapsules.
Shutava TG; Balkundi SS; Lvov YM
J Colloid Interface Sci; 2009 Feb; 330(2):276-83. PubMed ID: 19027120
[TBL] [Abstract][Full Text] [Related]
45. Antioxidant Nanocomplexes for Delivery of Epigallocatechin-3-gallate.
Hu B; Ma F; Yang Y; Xie M; Zhang C; Xu Y; Zeng X
J Agric Food Chem; 2016 May; 64(17):3422-9. PubMed ID: 27064900
[TBL] [Abstract][Full Text] [Related]
46. Effect of epigallocatechin gallate on the body composition and lipid profile of down syndrome individuals: Implications for clinical management.
Xicota L; Rodríguez J; Langohr K; Fitó M; Dierssen M; de la Torre R;
Clin Nutr; 2020 Apr; 39(4):1292-1300. PubMed ID: 31229326
[TBL] [Abstract][Full Text] [Related]
47. Lipophilization of EGCG and effects on antioxidant activities.
Liu B; Yan W
Food Chem; 2019 Jan; 272():663-669. PubMed ID: 30309596
[TBL] [Abstract][Full Text] [Related]
48. Resveratrol and Epigallocatechin-3-gallate addition to thawed boar sperm improves in vitro fertilization.
Gadani B; Bucci D; Spinaci M; Tamanini C; Galeati G
Theriogenology; 2017 Mar; 90():88-93. PubMed ID: 28166993
[TBL] [Abstract][Full Text] [Related]
49. The Impact of Lipid Types and Liposomal Formulations on Osteoblast Adiposity and Mineralization.
Chang SF; Yeh CC; Chen PJ; Chang HI
Molecules; 2018 Jan; 23(1):. PubMed ID: 29301300
[TBL] [Abstract][Full Text] [Related]
50. Antioxidant activity, storage stability and in vitro release of epigallocatechin-3-gallate (EGCG) encapsulated in hordein nanoparticles.
Song H; Wang Q; He A; Li S; Guan X; Hu Y; Feng S
Food Chem; 2022 Sep; 388():132903. PubMed ID: 35436635
[TBL] [Abstract][Full Text] [Related]
51. Amelioration of lipid profile and level of antioxidant activities by epigallocatechin-gallate in a rat model of atherogenesis.
Xu X; Pan J; Zhou X
Heart Lung Circ; 2014 Dec; 23(12):1194-201. PubMed ID: 25027849
[TBL] [Abstract][Full Text] [Related]
52. Investigation of the Effect of Different Emulsifiers on the Transdermal Delivery of EGCG Entrapped in a Polymeric Micelle System.
Casiraghi A; Franzè S; Selmin F; Dazio V; Minghetti P
Planta Med; 2017 Mar; 83(5):405-411. PubMed ID: 27286328
[TBL] [Abstract][Full Text] [Related]
53. Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studies.
Fangueiro JF; Calpena AC; Clares B; Andreani T; Egea MA; Veiga FJ; Garcia ML; Silva AM; Souto EB
Int J Pharm; 2016 Apr; 502(1-2):161-9. PubMed ID: 26921515
[TBL] [Abstract][Full Text] [Related]
54. Molecular binding of catechins to biomembranes: relationship to biological activity.
Sirk TW; Brown EF; Friedman M; Sum AK
J Agric Food Chem; 2009 Aug; 57(15):6720-8. PubMed ID: 19572638
[TBL] [Abstract][Full Text] [Related]
55. Photodegradation of (-)-epigallocatechin-3-gallate in topical cream formulations and its photostabilization.
Bianchi A; Marchetti N; Scalia S
J Pharm Biomed Anal; 2011 Dec; 56(4):692-7. PubMed ID: 21807473
[TBL] [Abstract][Full Text] [Related]
56. Covalent modification of proteins by green tea polyphenol (-)-epigallocatechin-3-gallate through autoxidation.
Ishii T; Mori T; Tanaka T; Mizuno D; Yamaji R; Kumazawa S; Nakayama T; Akagawa M
Free Radic Biol Med; 2008 Nov; 45(10):1384-94. PubMed ID: 18771724
[TBL] [Abstract][Full Text] [Related]
57. Chemiluminescence analysis of the prooxidant and antioxidant effects of epigallocatechin-3-gallate.
Tian B; Sun Z; Xu Z; Hua Y
Asia Pac J Clin Nutr; 2007; 16 Suppl 1():153-7. PubMed ID: 17392095
[TBL] [Abstract][Full Text] [Related]
58. Functional Properties of Novel Epigallocatechin Gallate Glucosides Synthesized by Using Dextransucrase from Leuconostoc mesenteroides B-1299CB4.
Kim J; Nguyen TT; Kim NM; Moon YH; Ha JM; Park N; Lee DG; Hwang KH; Park JS; Kim D
J Agric Food Chem; 2016 Dec; 64(48):9203-9213. PubMed ID: 27933996
[TBL] [Abstract][Full Text] [Related]
59. Structural characterization and antioxidant property of enzymatic-transesterification derivatives of (-)-epigallocatechin-3-O-gallate and vinyl laurate.
Jiang C; Wang L; Huang X; Zhu S; Ma C; Wang H
J Food Sci; 2021 Oct; 86(10):4717-4729. PubMed ID: 34553787
[TBL] [Abstract][Full Text] [Related]
60. Development of (-)-epigallocatechin-3-gallate (EGCG)-loaded enteric microparticles with intestinal mucoadhesive property.
Onoue S; Ochi M; Yamada S
Int J Pharm; 2011 May; 410(1-2):111-3. PubMed ID: 21419204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
